Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (211-220 of 743) with videos related to

Pageof 75
Sort By:
Oncotarget|February 1, 2021
Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference centerMarie-Luise Hilbers, Regula Brändli, Beda Mühleisen, et al.
Cancer|October 14, 2006
Molecularly targeted therapy for melanoma: current reality and future optionsJürgen C Becker, John M Kirkwood, Sanjiv S Agarwala, et al.
Journal of Cutaneous Pathology|November 22, 2012
Spindle-cell variant of primary cutaneous follicle center lymphoma spreading to the hepatobiliary tree, mimicking Klatskin tumorSima Rozati, Katrin Kerl, Werner Kempf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous lymphomasRudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
The association between immune checkpoint or BRAF/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanomaFlorentia Dimitriou, Ursula Urner-Bloch, Corinne Eggenschwiler, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center AnalysisLukas Kraehenbuehl, Stephanie Schneider, Laura Pawlik, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 26, 2026
Incidence, severity and potential pathomechanism of immune-related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapyAndrea Roggo, Nikolina Ivanovic, Patrick Turko, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2017
Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational studyDaniel Franzen, Karin Schad, Benedikt Kowalski, et al.
Experimental Dermatology|June 9, 2011
Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesionsKatharina Frey, Michael Fiechter, Kathrin Schwager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCLSima Rozati, Phil F Cheng, Daniel S Widmer, et al.
Pageof 75

Showing results (211-220 of 743) with videos related to

Sort By:
Pageof 75
Oncotarget|February 1, 2021
Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference centerMarie-Luise Hilbers, Regula Brändli, Beda Mühleisen, et al.
Cancer|October 14, 2006
Molecularly targeted therapy for melanoma: current reality and future optionsJürgen C Becker, John M Kirkwood, Sanjiv S Agarwala, et al.
Journal of Cutaneous Pathology|November 22, 2012
Spindle-cell variant of primary cutaneous follicle center lymphoma spreading to the hepatobiliary tree, mimicking Klatskin tumorSima Rozati, Katrin Kerl, Werner Kempf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 6, 2013
Brief S2k guidelines--Cutaneous lymphomasRudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
The association between immune checkpoint or BRAF/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanomaFlorentia Dimitriou, Ursula Urner-Bloch, Corinne Eggenschwiler, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center AnalysisLukas Kraehenbuehl, Stephanie Schneider, Laura Pawlik, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 26, 2026
Incidence, severity and potential pathomechanism of immune-related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapyAndrea Roggo, Nikolina Ivanovic, Patrick Turko, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2017
Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational studyDaniel Franzen, Karin Schad, Benedikt Kowalski, et al.
Experimental Dermatology|June 9, 2011
Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesionsKatharina Frey, Michael Fiechter, Kathrin Schwager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCLSima Rozati, Phil F Cheng, Daniel S Widmer, et al.
Pageof 75